An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

NCT ID: NCT01343901

Last Updated: 2017-04-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

210 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study will evaluate the efficacy and safety of bevacizumab as first-line treatment in participants with colorectal cancer and potentially resectable liver metastases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bevacizumab

Participants with metastatic colorectal cancer (mCRC) with exclusively liver or liver and lung metastases, who were receiving bevacizumab as part of first line treatment for potentially resectable liver metastases will be observed.

Bevacizumab

Intervention Type DRUG

Participants with mCRC and having exclusively liver or liver and lung metastases who were receiving bevacizumab as part of first line treatment for potentially resectable liver metastases as per treating physician's discretion will be observed. All concomitant medications as used in routine clinical practice are allowed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bevacizumab

Participants with mCRC and having exclusively liver or liver and lung metastases who were receiving bevacizumab as part of first line treatment for potentially resectable liver metastases as per treating physician's discretion will be observed. All concomitant medications as used in routine clinical practice are allowed.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Avastin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants with colorectal cancer with exclusively hepatic or hepatic and pulmonary metastases
* First-line treatment with bevacizumab for potentially resectable metastatic disease

Exclusion Criteria

* Outright resectable disease
* Clearly inoperable disease
* Participation in a clinical trial evaluating a cytotoxic anticancer treatment and/or an innovative therapy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Esquirol Saint Hilaire

Agen, , France

Site Status

C.H. Du Pays D'aix En Provence Service du Dr Blanc

Aix-en-Provence, , France

Site Status

Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire

Aix-en-Provence, , France

Site Status

Chi D Alencon; Medecine Ambulatoire

Alençon, , France

Site Status

Ch D Ales; Oncologie

Alès, , France

Site Status

Hopital Nord; Medecine A

Amiens, , France

Site Status

Clinique De L Europe; Pmsi

Amiens, , France

Site Status

Clinique De L Europe; Radiotherapie Chimiotherapie

Amiens, , France

Site Status

Centre Hospitalier de L'Agglomeration Montargeoise; Medecine Polyvalente A Orientation Mi & Cancero

Amilly, , France

Site Status

Hotel Dieu; Medecine A

Angers, , France

Site Status

Centre Radiotherapie Marie Curie

Arras, , France

Site Status

HOP Prive Arras Les Bonnettes; Chimiotherapie

Arras, , France

Site Status

Polyclinique Sainte Marguerite; Chimiotherapie

Auxerre, , France

Site Status

Chic Cote Basque Bayonne; Medecine II

Bayonne, , France

Site Status

Clinique Saint Etienne; Medecine

Bayonne, , France

Site Status

Centre Hospitalier; Hematologie-Oncologie

Beauvais, , France

Site Status

Ch de Belfort; Hopital de Jour

Belfort, , France

Site Status

Hopital Jean Minjoz; Gastro Enterologie

Besançon, , France

Site Status

HOPITAL JEAN MINJOZ; Oncologie

Besançon, , France

Site Status

Centre Pierre Curie

Beuvry, , France

Site Status

Centre De Radiotherapie Oncodoc

Béziers, , France

Site Status

Clinique Champeau Mediterranee; Radiotherapie Oncologie

Béziers, , France

Site Status

Clinique Tivoli; Sce Radiotherapie

Bordeaux, , France

Site Status

Fondation Bergonie; Gastro-Enterologie

Bordeaux, , France

Site Status

Polyclin Bordeaux Nord Aquitaine; Gastro Enterologie

Bordeaux, , France

Site Status

Clinique Du Docteur Convert; Medecine

Bourg-en-Bresse, , France

Site Status

Centre Hospitalier Fleyriat; Oncologie/Hematologie

Bourg-en-Bresse, , France

Site Status

Ch De Fleyriat; Gastro Enterologie

Bourg-en-Bresse, , France

Site Status

Ch Pierre Oudot; Gastro Enterologie

Bourgoin, , France

Site Status

Ch Jean Rougier; Oncologie Gastro Enterologie

Cahors, , France

Site Status

Infirmerie Protestante; Endos Digestive Coelioscopie

Caluire-et-Cuire, , France

Site Status

Ch Antoine Gayraud; Oncologie

Carcassonne, , France

Site Status

Cabinet Medical

Challes-les-Eaux, , France

Site Status

Ch de Chambery; Gastro Enterologie

Chambéry, , France

Site Status

Hopital Manchester; Gastro Enterologie

Charleville-Mézières, , France

Site Status

CH Du Cotentin Site De Cherbourg; Hopital De Jour

Cherbourg Octeville, , France

Site Status

Clinique Des Cedres; Medecine 2

Cornebarrieu, , France

Site Status

CHU Henri Mondor; Service d'Oncologie Medicale

Créteil, , France

Site Status

Ch De Dax; Radiotherapie Oncologie

Dax, , France

Site Status

Centre Leonard De Vinci;Chimiotherapie

Dechy, , France

Site Status

Cabinet

Dijon, , France

Site Status

Centre Georges Francois Leclerc; Oncologie 3

Dijon, , France

Site Status

Ch De La Dracenie; Hopital De Jour

Draguignan, , France

Site Status

Hopital Victor Jousselin; Gastro Enterologie

Druex, , France

Site Status

Hopital Simone Veil Eaubonne; Hopital De Jour

Eaubonne, , France

Site Status

Clinique Pasteur; Oncologie Medicale, Hematologie

Évreux, , France

Site Status

Ch Jacques Monod;Medecine A4 B4

Flers, , France

Site Status

Hopital De Freyming; Secteur 1

Freyming-Merlebach, , France

Site Status

Centre Gastro Loire

Gien, , France

Site Status

Hopital Nord Ouest;Gastro Enterologie

Gleizé, , France

Site Status

Hopital Alpha Sante De Hayange; Medecine B

Hayange, , France

Site Status

Clinique de L' Esperance; Oncologie

Hyères, , France

Site Status

Clinique Sainte Marguerite; Oncologie Medicale

Hyères, , France

Site Status

Polyclinique de Blois; Chimiotherapie Ambulatoire

La Chaussée-Saint-Victor, , France

Site Status

CH Dptal Les Oudairies; Gastro Enterologie

La Roche-sur-Yon, , France

Site Status

CH Dptal Les Oudairies; Hematologie Oncologie

La Roche-sur-Yon, , France

Site Status

Hopital Albert Michallon; Gastro Enterologie

La Tronche, , France

Site Status

Hopital Albert Michallon; Radiotherapie

La Tronche, , France

Site Status

Hopital Robert Boulin; Oncologie

Libourne, , France

Site Status

Cabinet Medical

Lille, , France

Site Status

Clinique Chenieux; Oncology

Limoges, , France

Site Status

Ch De Longjumeau; Hopital De Jour Et Semaine

Longjumeau, , France

Site Status

CH Bretagne Sud Site Bodelio; Oncologie Radiotherapie

Lorient, , France

Site Status

Clinique Des 4 Pavillons; Chimiotherapie

Lormont, , France

Site Status

Hia Desgenettes; Oncologie Hematologie

Lyon, , France

Site Status

Hopital De La Croix Rousse;Hepato Gastro Entero

Lyon, , France

Site Status

Clinique De La Sauvegarde; Chimiotherapie

Lyon, , France

Site Status

Ctre Hosp St Joseph Et St Luc; Gastro Enterologie Endoscopie

Lyon, , France

Site Status

Hopital Prive Jean Mermoz; Cancerologie

Lyon, , France

Site Status

Clinique Saint Faron; Sce Oncologie Radiotherapie

Mareuil-lès-Meaux, , France

Site Status

Fondation Hopital Saint Joseph; Gastro-Enterologie

Marseille, , France

Site Status

Ch De Meaux; Gastro Enterologie

Meaux, , France

Site Status

Hopital Clinique Claude Bernard; Oncologie Medicale

Metz, , France

Site Status

Chra; Gastro Enterologie

Metz-Tessy, , France

Site Status

Hopital Layne; Medecine Ambulatoire

Mont-de-Marsan, , France

Site Status

Site Le Mittan; Hopital De Jour

Montbéliard, , France

Site Status

Ch De Montelimar; Gastro Enterologie Oncologie

Montélimar, , France

Site Status

Ghi Le Raincy Montfermeil; Gastro Medecine Interne

Montfermeil, , France

Site Status

Ghi Le Raincy Montfermeil; Radiotherapie Oncologie

Montfermeil, , France

Site Status

Ctre Radiotherapie Joseph Belot; Hematologie

Montluçon, , France

Site Status

Polyclinique Saint Roch; Hop Jour Chimio Radiotherapie

Montpellier, , France

Site Status

Centre Azureen De Cancerologie; Cons externes

Mougins, , France

Site Status

Polyclinique Gentilly; CHIMIOTHERAPIE AMBULATOIRE

Nancy, , France

Site Status

Polyclinique Du Languedoc; Chimiotherapie

Narbonne, , France

Site Status

Ch De Nemours; Medecine 1

Nemours, , France

Site Status

Clinique Du Parc Imperial; Chimiotherapie

Nice, , France

Site Status

Hopital De L Archet;Gastro Nutrition Oncologie

Nice, , France

Site Status

Hopital Caremeau; Gastro Enterologie

Nîmes, , France

Site Status

Hopital Des Diaconesses; Hopital De Jour

Paris, , France

Site Status

Ch Pitie Salpetriere; Oncologie Medicale

Paris, , France

Site Status

GH Paris Saint Joseph; Hopital De Jour Oncologie

Paris, , France

Site Status

Hopital Bichat Claude Bernard; Hepatologie Gastro Enterologie

Paris, , France

Site Status

HOPITAL TENON; Cancerologie Medicale

Paris, , France

Site Status

Centre Catalan D' Oncologie

Perpignan, , France

Site Status

Hopital Saint Jean; Centre Henri Pujol

Perpignan, , France

Site Status

Hopital Du Haut-Leveque; Gastro-Enterologie

Pessac, , France

Site Status

Clinique Francheville; Radiotherapie

Périgueux, , France

Site Status

Ch De Perigueux; Had Perigueux

Périgueux, , France

Site Status

Ch Lyon Sud; Gastro Secteur Jules Courmont

Pierre-Bénite, , France

Site Status

Clinique Armoricaine Radiologie; Hopital de Jour

Plérin, , France

Site Status

Chu La Miletrie; Gastro Enterologie Endoscopies

Poitiers, , France

Site Status

Hopital Rene Dubos; Service de Medecine Generale & de Gastro-Enterologie

Pontoise, , France

Site Status

Centre Eugene Marquis; Unite Huguenin

Rennes, , France

Site Status

Hopital Charles Nicolle; Endoscopies Digestives

Rouen, , France

Site Status

Clinique De L Europe; Chimiotherapie

Rouen, , France

Site Status

Clinique Saint Hilaire; Sce Chimiotherapie

Rouen, , France

Site Status

Hopital Yves Le Foll; Hepatologie Gastro Enterologie

Saint-Brieuc, , France

Site Status

Chi Poissy Saint Germain En Laye; Centre Coordination Cancerologie

Saint-Germain-en-Laye, , France

Site Status

Chp Saint Gregoire; Cancerologie Radiotherapie

Saint-Grégoire, , France

Site Status

Ico Rene Gauducheau; Oncologie

Saint-Herblain, , France

Site Status

Clinique de L'Union; Oncologie

Saint-Jean, , France

Site Status

Memorial France Etats Unis; Hopital De Jour

Saint-Lô, , France

Site Status

CMCO De La Cote D Opale; Auberge De Jour

Saint-Martin-Boulogne, , France

Site Status

Cabinet Medical

Saint-Priest, , France

Site Status

Centre Hospitalier General; Oncologie Medicale

Salouël, , France

Site Status

Clinique Chir De L Orangerie; Chimiotherapie

Strasbourg, , France

Site Status

Clinique Saint Anne; Hopital De Jour

Strasbourg, , France

Site Status

Centre Paul Strauss; Oncologie Medicale

Strasbourg, , France

Site Status

Clinique Sainte Anne; Hospitalisation

Strasbourg, , France

Site Status

Hopital Font Pre; Hemato-Oncologie

Toulon, , France

Site Status

Hopital Purpan; Chir Generale Digestive

Toulouse, , France

Site Status

Clinique Pasteur; Oncologie Medicale

Toulouse, , France

Site Status

Hopital Saint Nicolas; Medecine A

Verdun, , France

Site Status

Hopital Jacques Lacarin; Hopital De Jour

Vichy, , France

Site Status

Hopital Paul Brousse; Hematologie

Villejuif, , France

Site Status

Chi De Villeneuve St Georges; Oncologie

Villeneuve-Saint-Georges, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ML22999

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.